Table 2. Patient characterization and analyses performed.
Patient N° | Gender | Diagnosis | Karyotype | Molecular Biology | Apoptosis | mRNA | Protein |
---|---|---|---|---|---|---|---|
1 | M | AML 2 | 46;XY; t(9;11) | MLLT3-MLL | no | no | yes |
2 | M | AML 2 | 46;XY | CEBP alpha | no | yes | no |
3 | F | AML 1 | 46;XX | FLT3 mut | yes | no | no |
4 | M | sAML | 46;XY | FLT3 mut | yes | no | no |
5 | M | AML 2 | 46;XY | dup MLL | no | yes | no |
6 | F | AML 1 | 46;XX | dup MLL | no | yes | no |
7 | M | AML 5a | 46;XY | FLT3 ITD/dup MLL | no | yes | no |
8 | M | sAML | 46;XY; del(3)(q?),-7 | FLT3 ITD / EVI1 | yes | no | no |
9 | M | AML 5a | 46;XY | FLT3 ITD | yes | no | no |
10 | F | AML 2 | 46;XX | FLT3 ITD | no | yes | no |
11 | M | AML | 46;XY | FLT3 ITD | no | yes | no |
12 | F | AML | 47;XX; der(10)(?) | FLT3 ITD | no | yes | no |
13 | F | AML 1 | 46;XX | NPM1 + FLT3 ITD | no | yes | no |
14 | F | sAML | 46;XX | NPM1 + FLT3 ITD | yes | no | no |
15 | M | AML 4 | 46;XY | NPM1 + FLT3 ITD | yes | no | no |
16 | M | AML 5 | 46;XY | NPM1 + FLT3 ITD | yes | no | yes |
17 | M | AML 4 | 46;XY | NPM1 + FLT3 ITD | yes | no | no |
18 | M | AML 2 | 46;XY | NPM1 + FLT3 ITD | yes | no | no |
19 | F | AML 2 | 46;XX | NPM1 | no | yes | no |
20 | F | AML 2 | 46;XX | NPM1 | no | yes | no |
21 | M | AML 4 | 46;XY | NPM1 | no | yes | no |
22 | M | AML 4 | 46;XY | NPM1 | no | yes | no |
23 | F | AML 4 | 46;XX | NPM1 | no | yes | no |
24 | M | AML 1 | 46;XY | NPM1 | no | yes | no |
25 | M | AML 2 | 46;XY | NPM1 | no | yes | no |
26 | F | AML 4eo | 46;XX; inv(16)(p13q22) | CBFb/MYH11 | yes | yes | yes |
27 | F | AML 4eo | 46;XX; inv(16)(p13q22) | CBFb/MYH11 | yes | yes | no |
28 | M | AML 4eo | 46;XY; inv(16)(p13q22) | CBFb/MYH11 | yes | yes | no |
29 | M | AML 4eo | 46;XY; inv(16)(p13q22) | CBFb/MYH11 | no | yes | no |
30 | F | AML 4eo | 46;XX; inv(16)(p13q22) | CBFb/MYH11 | no | yes | no |
31 | F | AML 2 | 46;XX; t(8;21) | AML1-ETO | yes | no | no |
32 | M | AML 2 | 46;XY; t(8;21) | AML1-ETO | no | yes | no |
33 | M | AML 2 | 46;XY; t(8;21) | AML1-ETO | no | yes | no |
34 | F | AML | Complex | ND | no | yes | no |
35 | F | AML | Complex | ND | no | yes | no |
36 | M | AML | Complex | ND | no | yes | no |
37 | M | AML | Complex | ND | no | yes | no |
38 | F | AML 5 | Complex | ND | yes | yes | no |
39 | F | ALL-B | Complex | Ikaros del | no | yes | no |
40 | F | ALL-B | Complex | Ikaros del | yes | yes | no |
41 | M | ALL-B | 46;XY | ND | no | yes | no |
42 | F | ALL-B | 46;XX | ND | no | yes | no |
43 | M | ALL-B | 46;XY; t(9;22) | BCR-ABL | yes | no | yes |
44 | M | ALL-B | 46;XY; t(9;22) | BCR-ABL | no | yes | no |
45 | F | ALL-B | 46;XX; t(9;22) | BCR-ABL | no | yes | no |
46 | M | ALL-B | 46;XY; t(9;22) | BCR-ABL | no | yes | no |
47 | M | ALL-B | 46;XY; t(9;22) | BCR-ABL | no | yes | no |
48 | M | ALL-T | 46;XY; del(7)(p?) | HOX11L2 | no | yes | no |
49 | F | ALL-T | Complex | ND | no | yes | no |
50 | F | ALL-T | Complex | ND | no | yes | no |
51 | M | ALL-T | Complex | ND | no | yes | no |
52 | M | ALL-T | ND | Calm/Af10 | no | yes | no |